🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, asserting the corporations concealed safety concerns that the pain reliever presented to pediatric neurological development.

The court filing follows thirty days after President Donald Trump publicized an unproven link between consuming Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which once produced the medication, the sole analgesic recommended for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he said they "betrayed America by profiting off of suffering and pushing pills without regard for the dangers."

The company states there is no credible evidence connecting acetaminophen to autism.

"These companies deceived for years, deliberately risking countless individuals to increase profits," Paxton, from the Republican party, said.

Kenvue commented that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the well-being of American women and children."

On its website, the company also said it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a proven link between consuming paracetamol and autism spectrum disorder."

Groups representing physicians and medical practitioners agree.

ACOG has declared acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to address discomfort and fever, which can create major wellness concerns if ignored.

"In more than two decades of research on the consumption of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the usage of paracetamol in any trimester of gestation causes brain development issues in young ones," the group said.

The court filing mentions recent announcements from the former administration in arguing the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he instructed pregnant women to "struggle intensely" not to use Tylenol when ill.

The FDA then released a statement that physicians should consider limiting the use of Tylenol, while also declaring that "a causal relationship" between the drug and autism in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in spring to conduct "extensive scientific investigation" that would determine the source of autism in a short period.

But experts warned that finding a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and condition that affects how persons experience and interact with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - who supports Trump who is campaigning for US Senate - claims the manufacturer and J&J "willfully ignored and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the companies "eliminate any commercial messaging" that asserts acetaminophen is reliable for women during pregnancy.

This legal action parallels the complaints of a collection of guardians of children with autism and ADHD who took legal action against the makers of acetaminophen in two years ago.

Judicial authorities threw out the legal action, saying investigations from the plaintiffs' authorities was lacking definitive proof.